AJUBA divergent transcript (AJUBA-DT)

The AJUBA divergent transcript (AJUBA-DT) is a long non-coding RNA (lncRNA) associated with the AJUBA gene locus[5]. Divergent transcripts typically arise from promoter regions and are transcribed in the direction opposite to the main protein-coding gene (in this case, AJUBA) but generally do not code for proteins[2]. While divergent transcription is a widespread phenomenon thought to contribute to gene regulation and novel gene evolution, there is no established evidence that AJUBA-DT encodes a protein, functions as a receptor, or has a validated therapeutic target role in human biology or disease[2][5]. Is this considered a therapeutic target? AJUBA-DT is not a classical or established drug target. Most pharmacologically actionable targets are proteins (such as receptors, enzymes, or transporters), whereas AJUBA-DT is a non-coding RNA gene with poorly defined molecular or clinical functions[5]. Is there something wrong with this name as a target? AJUBA-DT is not the protein-coding AJUBA LIM protein (a signal transducer implicated in cell adhesion, Hippo signaling, and cancer)[1][3][6]. The AJUBA protein is a target of biomedical interest, but AJUBA-DT (the divergent transcript) is not. There is significant risk of confusing these two. Molecular classification: AJUBA-DT encodes an lncRNA, placing it under "Other" for molecular classification (not a GPCR, receptor, enzyme, etc.)[2][5]. Summary: AJUBA-DT is a long non-coding RNA gene partner to the AJUBA locus, not a canonical therapeutic target. If you are searching for information related to the druggable LIM protein "Ajuba," do not use AJUBA-DT; use "Ajuba" or "Ajuba LIM domain protein" instead[1][3][6][5].

Other names

AJUBA-DTAJUBA divergent transcript

None established